SomnoMed Ltd (ASX: SOM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
SomnoMed Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
SomnoMed Ltd (ASX: SOM)
Latest News
Share Fallers
The Medical Developments share price is now down 49% over the past year
Share Fallers
Why the SomnoMed Limited share price is falling today
Share Gainers
Why these 4 ASX shares are storming higher today
Share Gainers
Why these 4 ASX shares have started the week with a bang
Share Fallers
Why these 4 ASX shares are ending the week in the red
Speculative
Resapp Health Ltd (ASX:RAP) suspends trade on Smartcough results
Share Fallers
ResApp Health Ltd (ASX:RAP) shares slide lower despite strong obstructive sleep apnoea study results
ASX Share Market News
ALL ORDINARIES finishes lower Wednesday: 8 shares you missed
Share Gainers
Why these 4 ASX shares have climbed higher today
⏸️ Investing
These shares just sank to 52-week lows
⏸️ Investing
Why these 4 ASX shares are tumbling lower today
⏸️ Investing
Why these 4 ASX shares have started the week in the red
SOM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About SomnoMed Ltd
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. The company was founded on March 16, 1987 and is headquartered in Sydney, Australia.
SOM Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Aug 2026 | $0.41 | $0.01 | 2.50% | 165,947 | $0.40 | $0.41 | $0.37 |
| 10 Aug 2026 | $0.40 | $-0.02 | -4.76% | 58,526 | $0.42 | $0.42 | $0.40 |
| 06 Aug 2026 | $0.42 | $0.00 | 0.00% | 20,020 | $0.42 | $0.42 | $0.42 |
| 05 Aug 2026 | $0.42 | $0.00 | 0.00% | 18,351 | $0.43 | $0.43 | $0.42 |
| 04 Aug 2026 | $0.42 | $-0.01 | -2.35% | 31,599 | $0.43 | $0.43 | $0.42 |
| 03 Aug 2026 | $0.43 | $-0.03 | -6.67% | 97,393 | $0.43 | $0.44 | $0.43 |
| 31 Jul 2026 | $0.45 | $-0.02 | -4.26% | 10,000 | $0.45 | $0.45 | $0.45 |
| 28 Jul 2026 | $0.47 | $0.00 | 0.00% | 1,000,001 | $0.47 | $0.47 | $0.47 |
| 27 Jul 2026 | $0.47 | $0.02 | 4.44% | 10,073 | $0.47 | $0.47 | $0.47 |
| 24 Jul 2026 | $0.45 | $-0.02 | -4.26% | 859 | $0.47 | $0.47 | $0.45 |
| 22 Jul 2026 | $0.47 | $0.05 | 11.90% | 127,848 | $0.45 | $0.47 | $0.45 |
| 21 Jul 2026 | $0.42 | $-0.02 | -4.60% | 136,654 | $0.44 | $0.47 | $0.42 |
| 20 Jul 2026 | $0.44 | $-0.03 | -6.52% | 22,198 | $0.45 | $0.46 | $0.44 |
| 17 Jul 2026 | $0.46 | $-0.02 | -4.17% | 130,356 | $0.46 | $0.46 | $0.46 |
| 16 Jul 2026 | $0.48 | $0.02 | 4.35% | 3,024 | $0.49 | $0.49 | $0.48 |
| 15 Jul 2026 | $0.46 | $0.00 | 0.00% | 88,850 | $0.46 | $0.47 | $0.46 |
| 14 Jul 2026 | $0.46 | $-0.01 | -2.13% | 4,697 | $0.48 | $0.48 | $0.46 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 23 Jul 2026 | Karen Borg | Exercise | 575,000 | $270,250 |
Exercise of options.
|
| 23 Jul 2026 | Karen Borg | Buy | 575,000 | $270,250 |
Exercise of options.
|
| 04 Dec 2025 | Benjamin(Ben) Gisz | Issued | 200,000 | $160,000 |
Issue of options. As per announcement
|
| 04 Dec 2025 | Amrita Blickstead | Issued | 1,700,000 | $1,360,000 |
Issue of options.
|
| 04 Dec 2025 | Karen Borg | Issued | 1,700,000 | $1,360,000 |
Issue of options.
|
| 04 Dec 2025 | Michael Gordon | Issued | 200,000 | $160,000 |
Issue of options.
|
| 04 Dec 2025 | Gaetano (Guy) Russo | Issued | 600,000 | $480,000 |
Issue of options.
|
| 04 Dec 2025 | Andrew Price | Issued | 300,000 | $240,000 |
Issue of options.
|
| 16 Sep 2025 | Benjamin(Ben) Gisz | Sell | 13,211,430 | $9,248,001 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael Gordon | Non-Executive Director | Aug 2020 |
Mr Gordon is the Director of Koala Company Limited, a direct-to-consumer household goods retailer. Michael was previously the CFO of Rokt, a marketing technology company, and CFO of Different Technologies, a property technology company. Prior to these, Michael was the Group CFO and MD Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Michael started his career with PricewaterhouseCoopers, spending 10 years with them in South Africa, the United Kingdom and Australia specializing in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is a Chairman of the Risk Committee.
|
| Mr Gaetano (Guy) Alfred Gerrard Russo | Non-Executive ChairmanNon-Executive Director | Aug 2020 |
Mr Russo has a commercial and customer-focused background working in Australia and internationally. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He has been a member of YPO since 2006, served as a member of the Business Council of Australia.
|
| Mr Andrew Price | Non-Executive Director | Jan 2025 |
Mr Price is an executive in the medical device industry, has spent the last 25 years at ResMed in various senior roles. Prior to finishing his employment with ResMed, Andrew was Chief Supply Chain Officer, leading all functions of the end-to-end supply chain including supplier management, manufacturing, logistics, distribution, quality assurance and regulatory affairs. Andrew held roles at ResMed across product development, project management and business development globally. He is a member of the Risk Committee.
|
| Mr Benjamin(Ben) Gisz | Non-Executive Director | Oct 2024 |
Mr Gisz is a director and member of the investment team at TDM Growth Partners, an investment firm specializing in long-term investments in high-growth companies globally. Ben has investment, corporate advisory and financial markets experience, including prior roles with Investec Group and Credit Suisse. Ben is a current Non-Executive Director at Australian pet supplies ecommerce business Pet Circle. He is a member of Risk Committee.
|
| Ms Karen Borg | Executive DirectorChief Executive Officer | Feb 2024 |
Ms Borg has held senior roles in FTSE 100-250 medical devices, technology, consumer products and government services organizations. Karen was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Karen began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing. Karen is on the Board of KOPWA Aged Care Services and was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance.
|
| Mr Terence Anthony Flitcroft | Company Secretary |
-
|
|
| Ye-Fei Guo | Chief Financial Officer |
-
|
|
| Terence Anthony Flitcroft | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Hsbc Custody Nominees (Australia) Limited | 110,635,851 | 51.20% |
| J P Morgan Nominees Australia Pty Limited | 11,013,948 | 5.10% |
| Dottie Investments Pty Ltd | 9,166,619 | 4.24% |
| Mutual Trust Pty Ltd | 7,746,054 | 3.58% |
| Howarth PAF Pty Ltd <The Howarth Foundation A/C> | 5,415,675 | 2.51% |
| Equity Plan Services Pty Ltd | 4,582,482 | 2.12% |
| BNP Paribas Nominees Pty Ltd <Clearstream> | 4,287,467 | 1.98% |
| Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> | 3,100,000 | 1.43% |
| Timbina Pty Limited <Timbina Super Fund A/C> | 2,696,297 | 1.25% |
| Ginga Pty Ltd | 2,444,216 | 1.13% |
| Ginga Pty Ltd <TG Klinger S/F A/C> | 2,367,685 | 1.10% |
| P Neustadt Holdings Pty Limited <Belgove Super Fund A/C> | 2,353,628 | 1.09% |
| Mr Gaetano Alfred Gerrard <Rusbev Super FD A/C> | 2,055,220 | 0.95% |
| Belgove Pty Ltd | 1,853,265 | 0.86% |
| Golden Words Pty Ltd | 1,650,419 | 0.76% |
| Dinwoodie Investments Pty Ltd | 1,584,612 | 0.73% |
| REM Medical Pty Ltd <Cocoon Super Fund A/C> | 1,342,801 | 0.62% |
| Howarth PAF Pty Limited <Howarth Charitable Fund A/C> | 1,315,225 | 0.61% |
| Howarth Commercial Pty Limited | 1,174,670 | 0.54% |
| Dinwoodie Investments Pty Ltd <Dinwoodie Investments A/C> | 1,164,286 | 0.55% |